BioMed Research International / 2016 / Article / Tab 2

Research Article

Factors Affecting Adverse Drug Reaction Reporting of Healthcare Professionals and Their Knowledge, Attitude, and Practice towards ADR Reporting in Nekemte Town, West Ethiopia

Table 2

The knowledge status data of HCPs on ADR reporting in Nekemte town from January 2015 to June 2015.

VariableCategoryFrequency%

Heard about ADR-reportingYes8362.4
No5037.6

Information sourceIn-service training2427.6
Mass media67.2
Journals or publication910.8
Formal teaching3744.5
Peer group78.4

ADRs can be reported onDrugs4351.8
Medical devices1214.4
Both2833.7

Know about existence of yellow cardYes3137.4
No5262.6

Agents to which ADR is to be reportedI do not know2833.7
FMHACA2024.0
Health center1416.8
DTC/local drug monitor910.7
MD/physician67.2
Manufacturer33.6
Department of Pharmacy33.6

Know responsible bodyYes4130.8
No9269.1

To which drug do you expect more unexpected ADRs?Newly marketed drugs8765.4
Established drugs1410.5
I do not know3224.0

ADRs that should be reportedAll suspected reactions2015.0
Unknown/unexpected3324.8
Serious4030.1
Unexpected therapeutic effects2115.7
All1913.2

Mostly expected to be reportedExpected/labeled4533.8
Unexpected/unlabeled5440.6
I do not know3425.5

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.